Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Contemp Clin Trials. 2020 Nov 24;100:106228. doi: 10.1016/j.cct.2020.106228

Table 5.

Controller Medication Treatment Algorithm (Applied only to subjects currently taking controller medications)

Symptom Level (from Table 4) Treatment Algorithm for Participants with Acceptable Adherence (≥50% of prescribed controller doses taken) Treatment Algorithm for Participants with Unacceptable Adherence (< 50% of prescribed controller doses taken)

If participant has been on their current Step (1–6) for <6 weeks – no change in treatment If participant has been on their current Step (1–6) for <6 weeks – no change in treatment
Well Controlled (Symptom level 1) If participant has been on their current Step (1–6) for ≥6 weeks – decrease treatment by one step unless the participant has taken prednisolone for respiratory symptoms within the previous 28 days. If participant has been on their current Step (1–6) for ≥6 weeks – decrease treatment by one step unless the participant has taken prednisolone for respiratory symptoms within the previous 28 days.
Assess acute symptoms for initiation of prednisone Assess acute symptoms for initiation of prednisone

Not Well Controlled (Symptom level 2) If currently on Steps 1–5, increase controller regimen by 1 Step or, Continue same controller regimen or place on Step 2 therapy, whichever is higher
If currently on Step 6, continue Step 6
Assess acute symptoms for initiation of prednisone Assess acute symptoms for initiation of prednisone